GGrantIndex
← Leaderboards

Clinical Research Institute Of Montreal

Montreal, QC

Compare ↔
$11,834,764
Total funding
12
Grants

Funding over time

peak $2.7M · FY200516
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16

Funding mix

By agency

NIH$11,834,764 · 12

By mechanism

R01$8,488,946 · 9
DP3$2,509,367 · 1
R37$621,071 · 1
R21$215,380 · 1

Investigators at Clinical Research Institute Of Montreal

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

Not enough data

Emerging Leaders

6–10 yrs in

Not enough data

Largest grants

Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and sensor-augmented pump therapy in outpatient settings$2,509,367
DP3 · FY2015 · DK
STUDIES OF LUNG DISEASES OF HIV TRANSGENIC MICE$290,020
R01 · FY2006 · HL
GENETICS OF HEART AND KIDNEY DAMAGE IN HYPERTENSION$289,254
R01 · FY2001 · HL
STUDIES OF LUNG DISEASES OF HIV TRANSGENIC MICE$281,609
R01 · FY2009 · HL
STUDIES OF LUNG DISEASES OF HIV TRANSGENIC MICE$281,609
R01 · FY2007 · HL
STUDIES OF LUNG DISEASES OF HIV TRANSGENIC MICE$281,609
R01 · FY2008 · HL
STUDIES OF LUNG DISEASES OF HIV TRANSGENIC MICE$270,000
R01 · FY2005 · HL
PROTEIN PROFILING OF ORAL MUCOSA OF HIV TRANSGENIC MICE$270,000
R01 · FY2006 · DE
PROTEIN PROFILING OF ORAL MUCOSA OF HIV TRANSGENIC MICE$262,170
R01 · FY2007 · DE
GENETICS OF HEART AND KIDNEY DAMAGE IN HYPERTENSION$261,109
R01 · FY2004 · HL
PROTEIN PROFILING OF ORAL MUCOSA OF HIV TRANSGENIC MICE$259,286
R01 · FY2009 · DE
PROTEIN PROFILING OF ORAL MUCOSA OF HIV TRANSGENIC MICE$259,286
R01 · FY2008 · DE
PROTEIN PROFILING OF ORAL MUCOSA OF HIV TRANSGENIC MICE$256,693
R01 · FY2010 · DE
GENETICS OF HEART AND KIDNEY DAMAGE IN HYPERTENSION$255,629
R01 · FY2003 · HL
CARDIAC LESIONS IN HIV1 TRANSGENIC MICE$250,000
R01 · FY2001 · HL
CARDIAC LESIONS IN HIV1 TRANSGENIC MICE$250,000
R01 · FY2000 · HL
GENETICS OF HEART AND KIDNEY DAMAGE IN HYPERTENSION$249,030
R01 · FY2002 · HL
DEVELOPMENT OF RECEPTOR-SPECIFIC OPIOID PEPTIDE ANALOGS$226,571
R01 · FY2016 · DA
DEVELOPMENT OF RECEPTOR-SPECIFIC OPIOID PEPTIDE ANALOGS$223,630
R01 · FY2014 · DA
DEVELOPMENT OF RECEPTOR-SPECIFIC OPIOID PEPTIDE ANALOGS$222,813
R01 · FY2015 · DA